G101V (p.Gly101Val) variant of APP (Amyloid-beta precursor protein)

G101V (p.Gly101Val) in APP (Amyloid-beta precursor protein) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.75 / 1. The record also includes structural context.

G101V (p.Gly101Val) variant details